Ex-vivo expansion of red blood cells: How real for transfusion in humans?

Blood Reviews

Volumn 26, Issue 2, 2012, Pages 81-95

  Migliaccio, Anna Rita ^a,b   Masselli, Elena ^a   Varricchio, Lilian ^a   Whitsett, Carolyn ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Ex vivo generated erythroblasts; Glucocorticoids; Growth factors; Red blood cell transfusion

Indexed keywords

ANKYRIN; BLOOD GROUP ANTIGEN; ERYTHROPOIETIN; GLYCOPHORIN A; INTERLEUKIN 3; STEM CELL FACTOR; THROMBOSPONDIN; TRANSFERRIN RECEPTOR;

ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; CELL COUNT; CELL CULTURE; CELL EXPANSION; CELL THERAPY; CRYOPRESERVATION; DRUG DELIVERY SYSTEM; DRUG RESEARCH; EMBRYONIC STEM CELL; ERYTHROCYTE EXPANSION; ERYTHROCYTE LIFESPAN; ERYTHROCYTE STRUCTURE; ERYTHROCYTE TRANSFUSION; ERYTHROCYTE VOLUME; ERYTHROPOIESIS; EX VIVO STUDY; EXPERIMENTAL MODEL; GENE EXPRESSION PROFILING; HEMATOPOIETIC STEM CELL; HUMAN; LEUKAPHERESIS; MOLECULAR CLONING; MONONUCLEAR CELL; NONHUMAN; PATIENT SAFETY; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; RECOMBINANT DNA TECHNOLOGY; TECHNOLOGY;

BLOOD TRANSFUSION; CELL DIVISION; ERYTHROCYTES; HUMANS;

EID: 84856539022     PISSN: 0268960X     EISSN: 15321681     Source Type: Journal    
DOI: 10.1016/j.blre.2011.11.002     Document Type: Article

References (136)

1. The 2007 National Blood Collection and Utilization Survey Report 2008, DHHS, Washington, DC.
2. Ali A., Auvinen M.K., Rautonen J. The aging population poses a global challenge for blood services. Transfusion 2010, 50:584.
3. http://www.fda.gov/downloads/BiologicsBloodVaccines/SafetyAvailability/ReportalProblem/TrasfusionDonationFatalities/UCM254860.pdf.
4. Sullivan M.T., Cotten R., Read E.J., Wallace E.L. Blood collection and transfusion in the United States in 2001. Transfusion 2007, 47:385.
5. Zimrin A.B., Hess J.R. Current issues relating to the transfusion of stored red blood cells. Vox Sang 2009, 96:93.
6. Linden J.V., Wagner K., Voytovich A.E., Sheehan J. Transfusion errors in New York State: an analysis of 10 years' experience. Transfusion 2000, 40:1207.
7. Alter H.J., Klein H.G. The hazards of blood transfusion in historical perspective. Blood 2008, 112:2617.
8. Glynn S.A. Blood supply safety: an NHLBI perspective. Transfusion 2008, 48:1541.
9. Hod E.A., Zhang N., Sokol S.A., Wojczyk B.S., Francis R.O., Ansaldi D., et al. Transfusion of red blood cells after prolonged storage produces harmful effects that are mediated by iron and inflammation. Blood 2010, 115:4284.
10. Spahn D.R. Blood substitutes. Artificial oxygen carriers: perfluorocarbon emulsions. Crit Care 1999, 3:R93.
11. Natanson C., Kern S.J., Lurie P., Banks S.M., Wolfe S.M. Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death: a meta-analysis. JAMA 2008, 299:2304.
12. Hiroyama T., Miharada K., Sudo K., Danjo I., Aoki N., Nakamura Y. Establishment of mouse embryonic stem cell-derived erythroid progenitor cell lines able to produce functional red blood cells. PLoS One 2008, 3:e1544.
13. Papayannopulou T., Migliaccio A. Biology of Erythropoiesis, Erythroid Differentiation and Maturation. Hematology: Basic principle and Practice 2009, 276. [New York]. 5 ed. C. Livignstone (Ed.).
14. Orkin S.H., Zon L.I. Hematopoiesis: an evolving paradigm for stem cell biology. Cell 2008, 132:631.
15. Goldwasser E., White W.F., Taylor K.B. Further purification of sheep plasma erythropoietin. Biochim Biophys Acta 1962, 64:487.
16. Boyum A. Collection and handling of bone marrow suspensions for intravenous use. Scand J Clin Lab Invest 1962, 14:419.
17. Stephenson J.R., Axelrad A.A., McLeod D.L., Shreeve M.M. Induction of colonies of hemoglobin-synthesizing cells by erythropoietin in vitro. Proc Natl Acad Sci U S A 1971, 68:1542.
18. Orkin S.H., Harosi F.I., Leder P. Differentiation in erythroleukemic cells and their somatic hybrids. Proc Natl Acad Sci U S A 1975, 72:98.
19. Ogawa M., Grush O.C., O'Dell R.F., Hara H., MacEachern M.D. Circulating erythropoietic precursors assessed in culture: characterization in normal men and patients with hemoglobinopathies. Blood 1977, 50:1081.
20. Bender J.G., Unverzagt K.L., Walker D.E., Lee W., Van Epps D.E., Smith D.H., et al. Identification and comparison of CD34-positive cells and their subpopulations from normal peripheral blood and bone marrow using multicolor flow cytometry. Blood 1991, 77:2591.
21. Wong A., Yuen P.M., Li K., Yu A.L., Tsoi W.C. Cord blood collection before and after placental delivery: levels of nucleated cells, haematopoietic progenitor cells, leukocyte subpopulations and macroscopic clots. Bone Marrow Transplant 2001, 27:133.
22. Migliaccio A.R., Adamson J.W., Stevens C.E., Dobrila N.L., Carrier C.M., Rubinstein P. Cell dose and speed of engraftment in placental/umbilical cord blood transplantation: graft progenitor cell content is a better predictor than nucleated cell quantity. Blood 2000, 96:2717.
23. Randall T.D., Lund F.E., Howard M.C., Weissman I.L. Expression of murine CD38 defines a population of long-term reconstituting hematopoietic stem cells. Blood 1996, 87:4057.
24. Gibbs K.D., Gilbert P.M., Sachs K., Zhao F., Blau H.M., Weissman I.L., et al. Single-cell phospho-specific flow cytometric analysis demonstrates biochemical and functional heterogeneity in human hematopoietic stem and progenitor compartments. Blood 2011, 117:4226.
25. Gursoy A., Dogruk Unal A., Ayturk S., Karakus S., Nur Izol A., Bascil Tutuncu N., et al. Polycythemia as the first manifestation of Cushing's disease. J Endocrinol Invest 2006, 29:742.
26. Dukes P.P., Goldwasser E. Inhibition of erythropoiesis by estrogens. Endocrinology 1961, 69:21.
27. Golde D.W., Bersch N., Cline M.J. Potentiation of erythropoiesis in vitro by dexamethasone. J Clin Invest 1976, 57:57.
28. Singer J.W., Adamson J.W. Steroids and hematopoiesis. III. The response of granulocytic and erythroid colony-forming cells to steroids of different classes. Blood 1976, 48:855.
29. Jacobs K., Shoemaker C., Rudersdorf R., Neill S.D., Kaufman R.J., Mufson A., et al. Isolation and characterization of genomic and cDNA clones of human erythropoietin. Nature 1985, 313:806.
30. Yang Y.C., Ciarletta A.B., Temple P.A., Chung M.P., Kovacic S., Witek-Giannotti J.S., et al. Human IL-3 (multi-CSF): identification by expression cloning of a novel hematopoietic growth factor related to murine IL-3. Cell 1986, 47:3.
31. Williams D.E., Eisenman J., Baird A., Rauch C., Van Ness K., March C.J., et al. Identification of a ligand for the c-kit proto-oncogene. Cell 1990, 63:167.
32. Martin F.H., Suggs S.V., Langley K.E., Lu H.S., Ting J., Okino K.H., et al. Primary structure and functional expression of rat and human stem cell factor DNAs. Cell 1990, 63:203.
33. Zsebo K.M., Williams D.A., Geissler E.N., Broudy V.C., Martin F.H., Atkins H.L., et al. Stem cell factor is encoded at the Sl locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor. Cell 1990, 63:213.
34. Migliaccio G., Migliaccio A.R., Druzin M.L., Giardina P.J., Zsebo K.M., Adamson J.W. Long-term generation of colony-forming cells in liquid culture of CD34+ cord blood cells in the presence of recombinant human stem cell factor. Blood 1992, 79:2620.
35. Fibach E., Manor D., Oppenheim A., Rachmilewitz E.A. Proliferation and maturation of human erythroid progenitors in liquid culture. Blood 1989, 73:100.
36. Bauer A., Tronche F., Wessely O., Kellendonk C., Reichardt H.M., Steinlein P., et al. The glucocorticoid receptor is required for stress erythropoiesis. Genes Dev 1999, 13:2996.
37. Dolznig H., Grebien F., Deiner E.M., Stangl K., Kolbus A., Habermann B., et al. Erythroid progenitor renewal versus differentiation: genetic evidence for cell autonomous, essential functions of EpoR, Stat5 and the GR. Oncogene 2006, 25:2890.
38. Migliaccio G., Masiello F., Tirelli V., Sanchez M., Varricchio L., Whitsett C., et al. Under HEMA conditions, self-replication of human erythroblasts is limited by autophagic death. Blood Cells Mol Dis 2011, 7:182.
39. Panzenbock B., Bartunek P., Mapara M.Y., Zenke M. Growth and differentiation of human stem cell factor/erythropoietin-dependent erythroid progenitor cells in vitro. Blood 1998, 92:3658.
40. von Lindern M., Zauner W., Mellitzer G., Steinlein P., Fritsch G., Huber K., et al. The glucocorticoid receptor cooperates with the erythropoietin receptor and c-Kit to enhance and sustain proliferation of erythroid progenitors in vitro. Blood 1999, 94:550.
41. Migliaccio G., Di Pietro R., di Giacomo V., Di Baldassarre A., Migliaccio A.R., Maccioni L., et al. In vitro mass production of human erythroid cells from the blood of normal donors and of thalassemic patients. Blood Cells Mol Dis 2002, 28:169.
42. Douay L., Lapillonne H., Turhan A.G. Stem cells-a source of adult red blood cells for transfusion purposes: present and future. Crit Care Clin 2009, 25:383.
43. Migliaccio G., Sanchez M., Masiello F., Tirelli V., Varricchio L., Whitsett C., et al. Humanized culture medium for clinical expansion of human erythroblasts. Cell Transplant 2010, 19:453.
44. Neildez-Nguyen T.M., Wajcman H., Marden M.C., Bensidhoum M., Moncollin V., Giarratana M.C., et al. Human erythroid cells produced ex vivo at large scale differentiate into red blood cells in vivo. Nat Biotechnol 2002, 20:467.
45. Giarratana M.C., Kobari L., Lapillonne H., Chalmers D., Kiger L., Cynober T., et al. Ex vivo generation of fully mature human red blood cells from hematopoietic stem cells. Nat Biotechnol 2005, 23:69.
46. Tirelli V., Ghinassi B., Migliaccio A., Whitsett C., Masiello F., Sanchez M., et al. Phenotypic definition of the progenitor cells with erythroid differentiation potential present in human adult blood. Stem Cell Int 2011, 2011:602483.
47. Varricchio L., Masselli E., Alfani E., Battistini A., Migliaccio G., Vannucchi A.M., et al. The dominant negative {beta} isoform of the glucocorticoid receptor is uniquely expressed in erythroid cells expanded from polycythemia vera patients. Blood 2011, 118:425.
48. Migliaccio A.R., Whitsett C., Migliaccio G. Erythroid cells in vitro: from developmental biology to blood transfusion products. Curr Opin Hematol 2009, 16:259.
49. Hayflick L., Moorhead P.S. The serial cultivation of human diploid cell strains. Exp Cell Res 1961, 25:585.
50. Hayflick L. The future of ageing. Nature 2000, 408:267.
51. England S.J., McGrath K.E., Frame J.M., Palis J. Immature erythroblasts with extensive ex vivo self-renewal capacity emerge from the early mammalian fetus. Blood 2011, 117:2708.
52. Wada H., Suda T., Miura Y., Kajii E., Ikemoto S., Yawata Y. Expression of major blood group antigens on human erythroid cells in a two phase liquid culture system. Blood 1990, 75:505.
53. Miller J.L., Njoroge J.M., Gubin A.N., Rodgers G.P. Prospective identification of erythroid elements in cultured peripheral blood. Exp Hematol 1999, 27:624.
54. Leberbauer C., Boulme F., Unfried G., Huber J., Beug H., Mullner E.W. Different steroids co-regulate long-term expansion versus terminal differentiation in primary human erythroid progenitors. Blood 2005, 105:85.
55. Keller M.A., Addya S., Vadigepalli R., Banini B., Delgrosso K., Huang H., et al. Transcriptional regulatory network analysis of developing human erythroid progenitors reveals patterns of coregulation and potential transcriptional regulators. Physiol Genomics 2006, 28:114.
56. Miharada K., Hiroyama T., Sudo K., Nagasawa T., Nakamura Y. Efficient enucleation of erythroblasts differentiated in vitro from hematopoietic stem and progenitor cells. Nat Biotechnol 2006, 24:1255.
57. Mabaera R., Richardson C.A., Johnson K., Hsu M., Fiering S., Lowrey C.H. Developmental- and differentiation-specific patterns of human gamma- and beta-globin promoter DNA methylation. Blood 2007, 110:1343.
58. Di Baldassarre A., Di Rico M., Di Noia A., Bonfini T., Iacone A., Marchisio M., et al. Protein kinase Calpha is differentially activated during neonatal and adult erythropoiesis and favors expression of a reporter gene under the control of the (A)gamma globin-promoter in cellular models of hemoglobin switching. J Cell Biochem 2007, 101:411.
59. Zhang X., Ma Y.N., Zhang J.W. Human erythroid progenitors from adult bone marrow and cord blood in optimized liquid culture systems respectively maintained adult and neonatal characteristics of globin gene expression. Biol Res 2007, 40:41.
60. Fujimi A., Matsunaga T., Kobune M., Kawano Y., Nagaya T., Tanaka I., et al. Ex vivo large-scale generation of human red blood cells from cord blood CD34+ cells by co-culturing with macrophages. Int J Hematol 2008, 87:339.
61. Ronzoni L., Bonara P., Rusconi D., Frugoni C., Libani I., Cappellini M.D. Erythroid differentiation and maturation from peripheral CD34+ cells in liquid culture: cellular and molecular characterization. Blood Cells Mol Dis 2008, 40:148.
62. Boehm D., Murphy W.G., Al-Rubeai M. The potential of human peripheral blood derived CD34+ cells for ex vivo red blood cell production. J Biotechnol 2009, 144:127.
63. Vlaski M., Lafarge X., Chevaleyre J., Duchez P., Boiron J.M., Ivanovic Z. Low oxygen concentration as a general physiologic regulator of erythropoiesis beyond the EPO-related downstream tuning and a tool for the optimization of red blood cell production ex vivo. Exp Hematol 2009, 37:573.
64. van den Akker E., Satchwell T.J., Pellegrin S., Daniels G., Toye A.M. The majority of the in vitro erythroid expansion potential resides in CD34(-) cells, outweighing the contribution of CD34(+) cells and significantly increasing the erythroblast yield from peripheral blood samples. Haematologica 2010, 95:1594.
65. Wojda U., Noel P., Miller J.L. Fetal and adult hemoglobin production during adult erythropoiesis: coordinate expression correlates with cell proliferation. Blood 2002, 99:3005.
66. Carlile G.W., Smith D.H., Wiedmann M. Caspase-3 has a nonapoptotic function in erythroid maturation. Blood 2004, 103:4310.
67. Brugger W., Mocklin W., Heimfeld S., Berenson R.J., Mertelsmann R., Kanz L. Ex vivo expansion of enriched peripheral blood CD34+ progenitor cells by stem cell factor, interleukin-1 beta (IL-1 beta), IL-6, IL-3, interferon-gamma, and erythropoietin. Blood 1993, 81:2579.
68. Tanavde V.M., Malehorn M.T., Lumkul R., Gao Z., Wingard J., Garrett E.S., et al. Human stem-progenitor cells from neonatal cord blood have greater hematopoietic expansion capacity than those from mobilized adult blood. Exp Hematol 2002, 30:816.
69. Nakagawa R., Watanabe T., Kawano Y., Kanai S., Suzuya H., Kaneko M., et al. Analysis of maternal and neonatal factors that influence the nucleated and CD34+ cell yield for cord blood banking. Transfusion 2004, 44:262.
70. Aroviita P., Teramo K., Westman P., Hiilesmaa V., Kekomaki R. Associations among nucleated cell, CD34+ cell and colony-forming cell contents in cord blood units obtained through a standardized banking process. Vox Sang 2003, 84:219.
71. Yu J., Leisenring W., Bensinger W.I., Holmberg L.A., Rowley S.D. The predictive value of white cell or CD34+ cell count in the peripheral blood for timing apheresis and maximizing yield. Transfusion 1999, 39:442.
72. Zhou J., Cidlowski J.A. The human glucocorticoid receptor: one gene, multiple proteins and diverse responses. Steroids 2005, 70:407.
73. Nicolaides N.C., Galata Z., Kino T., Chrousos G.P., Charmandari E. The human glucocorticoid receptor: molecular basis of biologic function. Steroids 2010, 75:1.
74. DeRijk R., de Kloet E.R. Corticosteroid receptor genetic polymorphisms and stress responsivity. Endocrine 2005, 28:263.
75. Hennighausen L., Robinson G.W. Interpretation of cytokine signaling through the transcription factors STAT5A and STAT5B. Genes Dev 2008, 22:711.
76. Stevens A., Donn R., Ray D. Regulation of glucocorticoid receptor gamma (GRgamma) by glucocorticoid receptor haplotype and glucocorticoid. Clin Endocrinol (Oxf) 2004, 61:327.
77. Migliaccio G., Sanchez M., Masiello F., Tirelli V., Varricchio L., Ghinassi B., et al. The γ Isoform of the Glucocorticoid Receptor Is Ontogenetically Activated and Predicts Poor Ex-Vivo Expansion of Erythroid Cells From Adult Blood. Blood 2009, 114.
78. Merryweather-Clarke A.T., Atzberger A., Soneji S., Gray N., Clark K., Waugh C., et al. Global gene expression analysis of human erythroid progenitors. Blood 2011, 117:e96.
79. Sposi N.M., Zon L.I., Care A., Valtieri M., Testa U., Gabbianelli M., et al. Cell cycle-dependent initiation and lineage-dependent abrogation of GATA-1 expression in pure differentiating hematopoietic progenitors. Proc Natl Acad Sci U S A 1992, 89:6353.
80. Peschle C., Gabbianelli M., Testa U., Pelosi E., Barberi T., Fossati C., et al. c-kit ligand reactivates fetal hemoglobin synthesis in serum-free culture of stringently purified normal adult burst-forming unit-erythroid. Blood 1993, 81:328.
81. Muta K., Krantz S.B., Bondurant M.C., Wickrema A. Distinct roles of erythropoietin, insulin-like growth factor I, and stem cell factor in the development of erythroid progenitor cells. J Clin Invest 1994, 94:34.
82. Chasis J.A., Mohandas N. Erythroblastic islands: niches for erythropoiesis. Blood 2008, 112:470.
83. Keerthivasan G., Small S., Liu H., Wickrema A., Crispino J.D. Vesicle trafficking plays a novel role in erythroblast enucleation. Blood 2010, 116:3331.
84. De Felice L., Tatarelli C., Mascolo M.G., Gregorj C., Agostini F., Fiorini R., et al. Histone deacetylase inhibitor valproic acid enhances the cytokine-induced expansion of human hematopoietic stem cells. Cancer Res 2005, 65:1505.
85. Araki H., Mahmud N., Milhem M., Nunez R., Xu M., Beam C.A., et al. Expansion of human umbilical cord blood SCID-repopulating cells using chromatin-modifying agents. Exp Hematol 2006, 34:140.
86. Araki H., Yoshinaga K., Boccuni P., Zhao Y., Hoffman R., Mahmud N. Chromatin-modifying agents permit human hematopoietic stem cells to undergo multiple cell divisions while retaining their repopulating potential. Blood 2007, 109:3570.
87. Chaurasia P., Berenzon D., Hoffman R. Chromatin-modifying agents promote the ex vivo production of functional human erythroid progenitor cells. Blood 2011, 117:4632.
88. Prchal J.T., Pastore Y.D. Erythropoietin and erythropoiesis: polycythemias due to disruption of oxygen homeostasis. Hematol J 2004, 5(Suppl. 3):S110.
89. Gerber H.P., Ferrara N. The role of VEGF in normal and neoplastic hematopoiesis. J Mol Med 2003, 81:20.
90. Zhang C.C., Lodish H.F. Insulin-like growth factor 2 expressed in a novel fetal liver cell population is a growth factor for hematopoietic stem cells. Blood 2004, 103:2513.
91. Hiroyama T., Miharada K., Aoki N., Fujioka T., Sudo K., Danjo I., et al. Long-lasting in vitro hematopoiesis derived from primate embryonic stem cells. Exp Hematol 2006, 34:760.
92. Olivier E.N., Qiu C., Velho M., Hirsch R.E., Bouhassira E.E. Large-scale production of embryonic red blood cells from human embryonic stem cells. Exp Hematol 2006, 34:1635.
93. Chang K.H., Nelson A.M., Fields P.A., Hesson J.L., Ulyanova T., Cao H., et al. Diverse hematopoietic potentials of five human embryonic stem cell lines. Exp Cell Res 2008, 314:2930.
94. Chang K.H., Huang A., Hirata R.K., Wang P.R., Russell D.W., Papayannopoulou T. Globin phenotype of erythroid cells derived from human induced pluripotent stem cells. Blood 2010, 115:2553.
95. Ye L., Chang J.C., Lin C., Sun X., Yu J., Kan Y.W. Induced pluripotent stem cells offer new approach to therapy in thalassemia and sickle cell anemia and option in prenatal diagnosis in genetic diseases. Proc Natl Acad Sci U S A 2009, 106:9826.
96. Peyrard T., Bardiaux L., Krause C., Kobari L., Lapillonne H., Andreu G., et al. Banking of pluripotent adult stem cells as an unlimited source for red blood cell production: potential applications for alloimmunized patients and rare blood challenges. Transfus Med Rev 2011, 25:206.
97. Bonig H., Chang K.H., Geisen C., Seifried E., Ware C. Blood types of current embryonic stem cell lines are not conducive to culturing "universal-donor" red blood cells. Transfusion 2008, 48:1039.
98. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663.
99. Olivieri N.F. The beta-thalassemias. N Engl J Med 1999, 341:99.
100. Peller S., Tabach Y., Rotschild M., Garach-Joshua O., Cohen Y., Goldfinger N., et al. Identification of gene networks associated with erythroid differentiation. Blood Cells Mol Dis 2009, 43:74.
101. Migliaccio G., Sanchez M., Leblanc A., Masiello F., Tirelli V., Migliaccio A.R., et al. Long-term storage does not alter functionality of in vitro generated human erythroblasts: implications for ex vivo generated erythroid transfusion products. Transfusion 2009, 49:2668.
102. Varricchio L., Fabucci M.E., Alfani E., Godbold J., Migliaccio A.R. Compensated variability in the expression of globin-related genes in erythroblasts generated ex vivo from different donors. Transfusion 2010, 50:672.
103. Macari E.R., Lowrey C.H. Induction of human fetal hemoglobin via the NRF2 antioxidant response signaling pathway. Blood 2011, 117:5987.
104. Gubin A.N., Njoroge J.M., Bouffard G.G., Miller J.L. Gene expression in proliferating human erythroid cells. Genomics 1999, 59:168.
105. Bruchova H., Yoon D., Agarwal A.M., Mendell J., Prchal J.T. Regulated expression of microRNAs in normal and polycythemia vera erythropoiesis. Exp Hematol 2007, 35:1657.
106. Noh S.J., Lee Y.T., Byrnes C., Miller J.L. A transcriptome-based examination of blood group expression. Transfus Clin Biol 2010, 17:120.
107. Singleton B.K., Burton N.M., Green C., Brady R.L., Anstee D.J. Mutations in EKLF/KLF1 form the molecular basis of the rare blood group In(Lu) phenotype. Blood 2008, 112:2081.
108. Sripichai O., Kiefer C.M., Bhanu N.V., Tanno T., Noh S.J., Goh S.H., et al. Cytokine-mediated increases in fetal hemoglobin are associated with globin gene histone modification and transcription factor reprogramming. Blood 2009, 114:2299.
109. Mabaera R., West R.J., Conine S.J., Macari E.R., Boyd C.D., Engman C.A., et al. A cell stress signaling model of fetal hemoglobin induction: what doesn't kill red blood cells may make them stronger. Exp Hematol 2008, 36:1057.
110. Kolbus A., Blazquez-Domingo M., Carotta S., Bakker W., Luedemann S., von Lindern M., et al. Cooperative signaling between cytokine receptors and the glucocorticoid receptor in the expansion of erythroid progenitors: molecular analysis by expression profiling. Blood 2003, 102:3136.
111. Turner M. The impact of new-variant Creutzfeldt-Jakob disease on blood transfusion practice. Br J Haematol 1999, 106:842.
112. Tolar J., Nauta A.J., Osborn M.J., Panoskaltsis Mortari A., McElmurry R.T., Bell S., et al. Sarcoma derived from cultured mesenchymal stem cells. Stem Cells 2007, 25:371.
113. Rubio D., Garcia-Castro J., Martin M.C., de la Fuente R., Cigudosa J.C., Lloyd A.C., et al. Spontaneous human adult stem cell transformation. Cancer Res 2005, 65:3035.
114. Bernardo M.E., Zaffaroni N., Novara F., Cometa A.M., Avanzini M.A., Moretta A., et al. Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms. Cancer Res 2007, 67:9142.
115. Selvaggi T.A., Walker R.E., Fleisher T.A. Development of antibodies to fetal calf serum with arthus-like reactions in human immunodeficiency virus-infected patients given syngeneic lymphocyte infusions. Blood 1997, 89:776.
116. Sakamoto N., Tsuji K., Muul L.M., Lawler A.M., Petricoin E.F., Candotti F., et al. Bovine apolipoprotein B-100 is a dominant immunogen in therapeutic cell populations cultured in fetal calf serum in mice and humans. Blood 2007, 110:501.
117. http://www.fda.gov/cber/ind/ind.htm.
118. Migliaccio G., Migliaccio A.R. Getting personal with B19 parvovirus. Blood 2010, 115:922.
119. Migliaccio A.R., Rotili D., Nebbioso A., Atweh G., Mai A. Histone deacetylase inhibitors and hemoglobin F induction in beta-thalassemia. Int J Biochem Cell Biol 2008, 40:2341.
120. Chen A.Y., Zhang E.Y., Guan W., Cheng F., Kleiboeker S., Yankee T.M., et al. The small 11 kDa nonstructural protein of human parvovirus B19 plays a key role in inducing apoptosis during B19 virus infection of primary erythroid progenitor cells. Blood 2010, 115:1070.
121. Jiang L., Lopez-Barragan M.J., Jiang H., Mu J., Gaur D., Zhao K., et al. Epigenetic control of the variable expression of a Plasmodium falciparum receptor protein for erythrocyte invasion. Proc Natl Acad Sci U S A 2010, 107:2224.
122. Tamez P.A., Liu H., Fernandez-Pol S., Haldar K., Wickrema A. Stage-specific susceptibility of human erythroblasts to Plasmodium falciparum malaria infection. Blood 2009, 114:3652.
123. Chang A.H., Stephan M.T., Lisowski L., Sadelain M. Erythroid-specific human factor IX delivery from in vivo selected hematopoietic stem cells following nonmyeloablative conditioning in hemophilia B mice. Mol Ther 2008, 16:1745.
124. Ragni MV K.C., Lozier J.M. Clinical aspects and therapy for hemophilia. Hematology: Basic Principles and Practice 2009, 1912. [New York]. 5th ed. C. Livigstone (Ed.).
125. Leonard M., Brice M., Engel J.D., Papayannopoulou T. Dynamics of GATA transcription factor expression during erythroid differentiation. Blood 1993, 82:1071.
126. Chang T.J., Scher B.M., Waxman S., Scher W. Inhibition of mouse GATA-1 function by the glucocorticoid receptor: possible mechanism of steroid inhibition of erythroleukemia cell differentiation. Mol Endocrinol 1993, 7:528.
127. Blobel G.A., Orkin S.H. Estrogen-induced apoptosis by inhibition of the erythroid transcription factor GATA-1. Mol Cell Biol 1996, 16:1687.
128. Blobel G.A., Sieff C.A., Orkin S.H. Ligand-dependent repression of the erythroid transcription factor GATA-1 by the estrogen receptor. Mol Cell Biol 1995, 15:3147.
129. Calado R.T., Yewdell W.T., Wilkerson K.L., Regal J.A., Kajigaya S., Stratakis C.A., et al. Sex hormones, acting on the TERT gene, increase telomerase activity in human primary hematopoietic cells. Blood 2009, 114:2236.
130. Schuller C.E., Jankowski K., Mackenzie K.L. Telomere length of cord blood-derived CD34(+) progenitors predicts erythroid proliferative potential. Leukemia 2007, 21:983.
131. Prade-Houdellier N., Frebet E., Demur C., Gautier E.F., Delhommeau F., Bennaceur-Griscelli A.L., et al. Human telomerase is regulated by erythropoietin and transforming growth factor-beta in human erythroid progenitor cells. Leukemia 2007, 21:2304.
132. Fibach E., Rachmilewitz E.A. The two-step liquid culture: a novel procedure for studying maturation of human normal and pathological erythroid precursors. Stem Cells 1993, 11(Suppl. 1):36.
133. Southcott M.J., Tanner M.J., Anstee D.J. The expression of human blood group antigens during erythropoiesis in a cell culture system. Blood 1999, 93:4425.
134. Pope S.H., Fibach E., Sun J., Chin K., Rodgers G.P. Two-phase liquid culture system models normal human adult erythropoiesis at the molecular level. Eur J Haematol 2000, 64:292.
135. Ji P., Yeh V., Ramirez T., Murata-Hori M., Lodish H.F. Histone deacetylase 2 is required for chromatin condensation and subsequent enucleation of cultured mouse fetal erythroblasts. Haematologica 2010, 95:2013.
136. Giarratana M.C., Rouard H., Dumont A., et al. Proof of principle for transfusion of in vitro-generated red blood cells. Blood 2011, 118:5071.